(S (NP-SBJ (NN Tyloxapol)) (VP-COOD (VP (VBZ inhibits) (NP (NP-COOD (NP (NN NF-kappa) (NN B)) (CC and) (NP (NN cytokine))) (NN release))) (, ,) (VP (VBZ scavenges) (NP (NN HOCI))) (, ,) (CC and) (VP (VBZ reduces) (NP (NP (NN viscosity)) (PP (IN of) (NP (JJ cystic) (NN fibrosis) (NN sputum)))))) (. .))
(S (NP-SBJ (NP (NP (JJ Cystic) (NN fibrosis)) (PRN (-LRB- -LRB-) (NP (NN CF)) (-RRB- -RRB-))) (NNS patients)) (VP (VB develop) (NP (NP (JJ progressive) (JJ cytokine-mediated) (JJ inflammatory) (NN lung) (NN disease)) (, ,) (PP (IN with) (NP (NP (JJ abundant) (NN production)) (PP (IN of) (NP (NP (ADJP-COOD (ADJP (JJ thick)) (, ,) (ADJP (JJ tenacious)) (, ,) (ADJP-COOD (ADJP (NP (NN protease-)) (ADJP (-NONE- *?*))) (CC and) (ADJP (JJ oxidant-rich)))) (JJ purulent) (NN airway) (NNS secretions)) (SBAR (WHNP-20 (WDT that)) (S (NP-SBJ (-NONE- *T*-20)) (VP (VBP are) (ADJP-PRD (JJ difficult) (SBAR (WHNP-21 (-NONE- 0)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB clear) (NP (-NONE- *T*-21)) (PP (RB even) (IN with) (NP (NN physiotherapy))))))))))))))))) (. .))
(S (PP (IN In) (NP (NP (DT the) (NN search)) (PP (IN for) (NP (DT a) (JJ potential) (NN treatment))))) (, ,) (NP-SBJ (PRP we)) (VP (VBP have) (VP (VBN tested) (NP (NP (NN tyloxapol)) (, ,) (NP (NP (DT an) (NN alkylaryl) (JJ polyether) (NN alcohol) (NN polymer) (NN detergent)) (VP (ADVP-TMP (RB previously)) (VBN used) (NP (-NONE- *)) (PP (IN as) (NP (DT a) (JJ mucolytic) (NN agent))) (PP (IN in) (NP (JJ adult) (JJ chronic) (NN bronchitis)))))))) (. .))
(S (NP-SBJ (NN Tyloxapol)) (VP-COOD (VP (VBZ inhibits) (NP (NP (NN activation)) (PP (IN of) (NP (DT the) (NN transcription) (NN factor) (NP (NP (JJ nuclear) (NN factor-kappa) (NN B)) (PRN (-LRB- -LRB-) (NP (NN NK-kappa) (NN B)) (-RRB- -RRB-))))))) (, ,) (VP (VBZ reduces) (NP (NP (VBG resting) (NN secretion)) (PP (IN of) (NP (NP (DT the) (NN cytokine) (NP (NP (NN interleukin-8)) (PRN (-LRB- -LRB-) (NP (NN IL-8)) (-RRB- -RRB-)))) (PP (IN in) (NP (VBN cultured) (JJ human) (NNS monocytes))))))) (, ,) (CC and) (VP (VBZ inhibits) (NP (NP (ADJP (NN lipopolysaccharide) (-LRB- -LRB-) (NN LPS) (-RRB- -RRB-) (JJ -stimulated)) (NN release)) (PP (IN of) (NP-COOD (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-))) (, ,) (NP (NN IL-1) (NN beta)) (, ,) (NP (NN IL-6)) (, ,) (NP (NN IL-8)) (, ,) (NP (NP (JJ granulocyte-macrophage) (JJ colony-stimulating) (NN factor)) (PRN (-LRB- -LRB-) (NP (NN GM-CSF)) (-RRB- -RRB-))) (, ,) (CC and) (NP (DT the) (NNS eiconsanoids) (NP-COOD (NP (NN thromboxane) (NN A2)) (CC and) (NP (NP (NN leukotriene) (NN B4)) (PRN (-LRB- -LRB-) (NP (NN LTB4)) (-RRB- -RRB-)))))))))) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP have) (ADVP-TMP (RB previously)) (VP (VBN shown) (SBAR (IN that) (S (NP-SBJ (NN tyloxapol)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ potent) (NN antioxidant)) (PP (IN for) (NP (NP (NN hydroxyl) (NNS radicals)) (PRN (-LRB- -LRB-) (NP (NN OH)) (-RRB- -RRB-)))))))))) (. .))
(S (NP-SBJ (NP (NN Tyloxapol)) (PRN (-LRB- -LRB-) (NP (ADJP (QP (CD 0.05) (TO to) (CD 0.1)) (NN %)) (NN (vol wt))) (-RRB- -RRB-))) (ADVP (RB effectively)) (VP-COOD (VP (VBZ scavenges) (NP (NP (DT the) (JJ oxidant) (JJ hypochlorous) (NN acid)) (PRN (-LRB- -LRB-) (NP (NP (NN HOCl)) (: ;) (NP (QP (CD 1) (TO to) (CD 7.5)) (NN mM))) (-RRB- -RRB-))) (ADVP (FW in) (FW vitro))) (, ,) (CC and) (VP (VBZ protects) (PP (IN from) (NP (JJ HOCl-mediated) (NN lung) (NN injury))) (PP (IN in) (NP (NNS rats))))) (. .))
(S (NP-SBJ (NN Tyloxapol)) (ADVP (RB also)) (VP (VBZ reduces) (NP (NP (DT the) (NN viscosity)) (PP (IN of) (NP (NN CF) (NN sputum)))) (-LRB- -LRB-) (PP (IN from) (NP (QP (CD 463) (CC (- +)) (CD 133)) (NP (-NONE- *RNR*-100)))) (PP (TO to) (NP (QP (CD 128) (CC (- +)) (CD 52)) (NP (-NONE- *RNR*-100)))) (NP-100 (NN centipoise)) (-RRB- -RRB-)) (. .))
(S (NP-SBJ (PRP We)) (VP (VBP conclude) (SBAR (IN that) (S (NP-SBJ (NN tyloxapol)) (VP-COOD (VP (VBZ is) (ADVP (RB potentially)) (ADJP-PRD (JJ useful) (PP (IN as) (NP (NP (DT a) (JJ new) (JJ antiinflammatory) (NN therapy)) (PP (IN for) (NP (NN CF) (NN lung) (NN disease))))))) (, ,) (CC and) (VP (MD could) (ADVP (RB possibly)) (VP (VB promote) (NP (NP (NN clearance)) (PP (IN of) (NP (NNS secretions))) (PP (IN in) (NP (DT the) (NN CF) (NN airway)))))))))) (. .))
